UNSPSC 41131709: Fibrin monomer paracoagulation test

In this classification a fibrin monomer paracoagulation test is a device used to detect fibrin monomer in the diagnosis of disseminated intravascular coagulation (non localized clotting within a blood vessel) or in the differential diagnosis between disseminated intravascular coagulation and primary fibrinolysis (dissolution of the fibrin in a blood clot) US FDA regulates Fibrin monomer Para coagulation test under 21 CFR 864.7300 and under FDA product code JBM.

UNSPSC 41131709 Fibrin monomer paracoagulation test is a Commodity code that, based on recent state and local solicitations, does not align with what governments are actually procuring under this classification. The code nominally covers a specific clinical laboratory assay for blood coagulation monitoring, yet the state and local opportunities posted under this code span drug testing services, occupational health screenings, laboratory supplies for forensic analysis, naloxone procurement, and urinalysis testing for treatment courts — none of which involve fibrin monomer paracoagulation testing. The actual scope of work being solicited includes offender drug testing with immunoassay and confirmatory testing (Collin County, Texas RFP for specimen collection and drug testing services), drug testing supplies compatible with analyzer systems (Gwinnett County, Georgia), forensic laboratory consumables and reagents for DNA and drug screening (Texas Comptroller statewide procurement), and drug and alcohol testing for safety-sensitive workforces (City of Charlotte). Issuing bodies include county criminal justice and corrections departments, county health care services, university procurement offices, state comptroller divisions, cities, and county purchasing departments — a broad mix across corrections, healthcare, and forensic laboratory operations.

Geographic activity spans Texas (Collin County offender testing RFP with estimated contract value of $600,000 and two-year initial term; Texas Comptroller proprietary laboratory equipment and supplies IFB with due date October 20, 2026), Georgia (Gwinnett County drug testing supplies RFB due October 14, 2026), North Carolina (City of Charlotte drug and alcohol testing RFP due October 12, 2026), New Mexico (Bernalillo County occupational health services RFP due October 8, 2026), Oregon (Benton County urinalysis testing for treatment court RFP due July 6, 2026; State of Oregon sole source procurement for clozapine assay kit from Saladax Biomedical posted May 4, 2026), Florida (Pinellas County forensic drug standards procurement through ITQ posted April 23, 2026 with Paul Coverdell federal funding totaling $72,126.85), and Wisconsin (University of Wisconsin-Madison implied consent blood draw kits RFB due August 3, 2026). The code shows recent activity but exhibits significant mismatch between the nominal commodity definition and the actual work being purchased, suggesting either systematic miscoding by issuing bodies or that the code name does not reflect the current state and local use case.